Optellum

The page covers essential insights on chronic lung diseases, including types, causes, diagnosis, and treatment options to improve patient outcomes.

Optellum’s Virtual Nodule Clinic, the only solution for lung nodule management, enables early lung cancer detection, prediction, and diagnosis to improve patient outcomes.

Achieve seamless EHR and PACS interoperability with Virtual Nodule Clinic, enhancing diagnosis and care coordination while ensuring HIPAA compliance and minimal workflow disruption.

The page provides information on lung cancer detection, diagnosis, and treatment, focusing on early diagnosis strategies and innovative technologies.

The page presents Optellum’s clinical evidence and publications on AI-powered lung cancer prediction, early detection, and nodule management, advancing precision care in lung disease.

Case studies and whitepapers demonstrate how Optellum’s AI solutions enhance lung cancer screening and management, improving return on investment and patient outcomes.

Optellum’s AI improves lung cancer diagnosis speed and accuracy at Georgia Cancer Center, increasing procedures and reimbursement through LCP technology.

Optellum’s media kit provides logos, brand resources, and information about its AI-powered lung care platform for early lung disease diagnosis and treatment.

Optellum offers career opportunities to contribute to AI-driven advancements in lung cancer diagnosis and treatment, improving patient outcomes.

Optellum is a commercial-stage AI healthcare company dedicated to revolutionizing early diagnosis and treatment of lung disease, starting with one of the deadliest, lung cancer.

Optellum develops AI-powered diagnostic support for lung cancer, including the world’s first FDA-cleared product, to aid clinicians in treatment decisions across the patient journey.

Global experts collaborate with Optellum to develop AI solutions for lung cancer diagnosis and treatment, improving patient care through advanced medical technology.

Optellum collaborates with global leaders to enhance early lung cancer diagnosis and treatment through research efforts, including a lung cancer detection reader study.

Optellum’s vision is to transform lung disease care with AI, enabling early detection and treatment of lung cancer and other conditions, improving outcomes and saving lives

Optellum is a lung health company developing the Lung Precision Care Platform, advancing early lung cancer detection and lung nodule management for optimal patient care

This Cookie Policy was last updated on March 10, 2021 and applies to citizens and legal permanent residents of the United Kingdom.

Optellum outlines data privacy practices, user rights, and processing methods in its privacy policy.

Optellum Ltd ensures digital accessibility, adhering to WCAG 2.1 level AA standards, and welcomes user feedback to enhance experience.